Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · IEX Real-Time Price · USD
0.351
+0.021 (6.48%)
At close: Apr 22, 2024, 4:00 PM
0.340
-0.011 (-3.24%)
After-hours: Apr 22, 2024, 6:27 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.34 million as of April 23, 2024. Its market cap has increased by 134.06% in one year.
Market Cap
2.34M
Enterprise Value
-5.10M
1-Year Change
134.06%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.34M, a decrease of -95.93%. That is a compound annual growth rate of -69.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 2.30M | 9.52% |
Apr 19, 2024 | 2.10M | -8.70% |
Apr 18, 2024 | 2.30M | 15.00% |
Apr 17, 2024 | 2.00M | 11.11% |
Apr 16, 2024 | 1.80M | -10.00% |
Apr 15, 2024 | 2.00M | -25.93% |
Apr 12, 2024 | 2.70M | - |
Apr 11, 2024 | 2.70M | -3.57% |
Apr 10, 2024 | 2.80M | 3.70% |
Apr 9, 2024 | 2.70M | -3.57% |
Apr 8, 2024 | 2.80M | - |
Apr 5, 2024 | 2.80M | - |
Apr 4, 2024 | 2.80M | 3.70% |
Apr 3, 2024 | 2.70M | -3.57% |
Apr 2, 2024 | 2.80M | - |
Apr 1, 2024 | 2.80M | 3.70% |
Mar 28, 2024 | 2.70M | 3.85% |
Mar 27, 2024 | 2.60M | -3.70% |
Mar 26, 2024 | 2.70M | -3.57% |
Mar 25, 2024 | 2.80M | - |
Mar 22, 2024 | 2.80M | 3.70% |
Mar 21, 2024 | 2.70M | 107.69% |
Mar 20, 2024 | 1.30M | 8.33% |
Mar 19, 2024 | 1.20M | - |
Mar 18, 2024 | 1.20M | -7.69% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sonoma Pharmaceuticals | 2.34M |
Altamira Therapeutics | 2.23M |
NanoVibronix | 2.23M |
CNS Pharmaceuticals | 2.15M |
Aclarion | 2.14M |
Salarius Pharmaceuticals | 2.13M |
Scinai Immunotherapeutics | 2.03M |
Qualigen Therapeutics | 2.01M |